Normal
0
false
false
false
EN-US
X-NONE
AR-SA
MicrosoftInternetExplorer4
Background: Amphibian
skins possess various antibacterial compounds that are effective against some
microbial pathogens and are mostly released in response to environmental
stress. In fact, the skin of Rana ridibunda, a large green frog, is a
rich source of antimicrobial compounds that can be developed for therapeutic
use. In the present study, the skin extract of Iranian Rana ridibunda was
evaluated for its antimicrobial, hemolytic and cytototoxic activities.
Methods : The frog specimens were collected from Minoodasht located in Golesten
province in Iran, during 2009. Subsequently, their skins were removed and the intended compounds
were extracted. The crude extract was partially purified by gel filtration
chromatography. The antimicrobial effects of skin extract were assessed against
various microorganisms such as Escherchia coli, methicillin-resistant
and -sensitive Staphyloccus aureus, vancomycin-resistant and -susceptible
Enteroccus fecalis, Pseudomonas aeroginosa and Candida albicans. In
addition, its minimum inhibition concentration, cytotoxic and hemolytic
activities were determined.
Results : The crude extract of Rana ridibunda skin had valuable
antimicrobial effects against methicillin-resistant and -susceptible S. aureus in comparison with E.coli and vancomycin-resistant
and -susceptible E. fecalis. Besides, no
antimicrobial activities were seen against P. aeroginosa or C. albicans. Moreover, the hemolytic and cytotoxic activities of the skin
extract were minimal.
Conclusion: The
antimicrobial activity of Iranian Rana ridibunda was comparable to those
isolated from other Rana species. In conclusion, the skin extract of Rana
ridibunda had the potential for a new therapeutic agent against the emerging
drug-resistant bacteria, particularly methicillin-resistant and -sensitive S.
aureus.
Background: The increasing use of β-lactam antibiotics in clinics for the treatment of different bacterial infections since early 1980s has led to increased rates of resistant bacteria isolated from patients. One of the problems in the treatment of nosocomial infections is related to resistant bacteria such as Enterobacter cloacae due to cross resistance through extended-spectrum beta-lactamase production. The aim of this study was to determine the prevalence of extended-spectrum beta-lactamase producing E. cloacae from different clinical specimens collected from hospitalized patients.
Methods: In the present study, 101 E. cloacae confirmed by standard specific microbiologic tests were collected from different specimens in Milad and Motahri hospitals in Tehran, Iran during February 2010 and September 2011. Antibiotic susceptibility tests were conducted according to the process recommended by the Clinical and Laboratory Standards Institute for 13 antibiotics of choice. Extended-spectrum beta-lactamase producing strains were screened for by combined disk method as a phenotypic diagnostic test.
Results: From a total of 101 E. cloacae, 33 (33%) were shown to produce extended-spectrum beta-lactamase by phenotypic tests 5% of the bacteria were resistant to imipenem too.
Conclusion: This study clearly showed the high prevalence of resistance to broad-spectrum beta-lactam antibiotics in the isolated E. cloacae among which 5% were multi drug resistant. All the isolated E. cloacae were susceptible to Colistin. These results can be alarming for physicians treating resistant E. cloacae infections, especially extended-spectrum beta-lactamase producing species.
|
Results: 92 patients, 23 men (25%) and 69 women (75%) with a mean age of 53.18±18.49 years were included in the study. Direct testing had a significant agreement with the standard test in 90.8% of the results (P<0.001). 9.2% of the antibiogram tests did not match, of which 0.3% were huge errors, 4.7% were major errors and 4.2% were minor errors. The highest number of microorganisms found were Escherichia coli (n=66), Klebsiella pneumoniae (n=13), Pseudomonas aeruginosa (n=6), Acinetobacter (n=1), Enterococcus (n=2), Alcaligenes (n=1), Streptococcus (n=1), Staphylococcus haemolyticus (n=1) and Moraxella (n=1) respectively. The highest rates of urinary tract infections were with Escherichia coli, third-generation cephalosporin antibiotics, and broad-spectrum antibiotics.
Conclusion: The agreement between the direct and standard antibiogram method was acceptable, and the direct antibiogram method can be cited by doctors in many cases. |
|
Results: In a cross-sectional descriptive study, 44 isolates of Salmonella Enteritidis from human sources were investigated between September 2022 and September 2023. 100% of the strains were sensitive to imipenem and meropenem, and the sensitivity to the antibiotics ceftriaxone, ceftazidime, and cefotaxime were 93.2%, 90.9%, and 94.1%, respectively. 81.8% of isolates were sensitive to cotrimoxazole, sensitivity to ampicillin was 84.1%. Only 9.1% of isolates were sensitive to ciprofloxacin. Based on MIC results, 16 isolates had MIC between 0.002 and 0.064 and were placed in the sensitive area. 28 isolates had MIC between 0.125 and 0.5 and were placed in the area of reduced sensitivity. None of the strains resistant to disk diffusion method were resistant to MIC method. qnrA, qnrB and qnrS genes were not observed among ciprofloxacin resistant strains. All nalidixic acid resistant strains had gyrA gene.
Conclusion: In general, it was shown in this study that the resistance to the fluoroquinolone family is increasing among Salmonella Enteritidis isolates. On the other hand, we see a decrease in the sensitivity and prevalence of strains resistant to broad-spectrum cephalosporins among serovar Enteritidis, which is the drug of choice for extraintestinal infections. |
|
Results: Of the 91 hospitalized patients, 70.3% (64 cases) were prescribed vancomycin without performing an antibiogram culture based on experience and 29.7% (27 cases) were based on an antibiogram culture. In 96.7% (88 cases) , the duration of intravenous vancomycin infusion did not comply with the protocol. Red Man Syndrome was observed in 8.8% (8 cases). In 91.2 % (83 cases), no adverse effects were reported. In 65.9% (60 cases), the drug dose was determined based on the correct renal function Glomerular filtration rate (GFR) and in 34.1%, the drug dose was determined regardless of the renal function of the patients. Vancomycin doses were lower and higher than the guidelines in 6 and 25 patients, respectively. Out of all patients, eighty four cases recovered and seven cases died.
Conclusion: In almost half of the patients, Vancomycin were prescribed based on experience and without performing an antibiogram test. Use of guidelines, Serum level monitoring programs and continuous medical education for doctors can be effective in rational use of antibiotics. |
| Page 1 from 1 |
© 2026 , Tehran University of Medical Sciences, CC BY-NC 4.0
Designed & Developed by : Yektaweb

